Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11858931 Amino acid compounds with unbranched linkers and methods of use

Patent 11858931 was granted and assigned to Pliant Therapeutics on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Pliant Therapeutics

Current Assignee

Pliant Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118589310

Patent Inventor Names

Jacob Cha0

Katerina Leftheris0

Darren Finkelstein0

Maureen Reilly0

Nicole Cooper0

Christopher Bailey0

Date of Patent

January 2, 2024

Patent Application Number

176790020

Date Filed

February 23, 2022

Patent Citations

‌

US Patent 10793564 Amino acid compounds and methods of use

‌

US Patent 11180494 Substituted amino acids as integrin inhibitors

‌

US Patent 11419869 Dosage forms and regimens for amino acid compounds

‌

US Patent 11634418 Amino acid compounds and methods of use

‌

US Patent 11560376 Amino acid compounds and methods of use

‌

US Patent 9572801 Tetrahydronaphthyridinyl propionic acid derivatives and uses thereof

‌

US Patent 10131658 Anti-alphavbeta1 integrin compounds and methods

‌

US Patent 10214552 Method for purifying beta-nicotinamide mononucleotide

...

Patent Primary Examiner

‌

Patrick T. Lewis

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11858931 Amino acid compounds with unbranched linkers and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API